X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SHASUN PHARMA with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA TTK HEALTHCARE SHASUN PHARMA/
TTK HEALTHCARE
 
P/E (TTM) x 123.9 51.2 242.0% View Chart
P/BV x 8.5 9.4 90.5% View Chart
Dividend Yield % 0.2 0.3 75.7%  

Financials

 SHASUN PHARMA   TTK HEALTHCARE
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
TTK HEALTHCARE
Mar-14
SHASUN PHARMA/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs94663 14.2%   
Low Rs46399 11.4%   
Sales per share (Unadj.) Rs214.2535.6 40.0%  
Earnings per share (Unadj.) Rs5.315.9 33.5%  
Cash flow per share (Unadj.) Rs15.820.0 79.0%  
Dividends per share (Unadj.) Rs1.004.00 25.0%  
Dividend yield (eoy) %1.40.8 190.0%  
Book value per share (Unadj.) Rs53.3137.6 38.8%  
Shares outstanding (eoy) m56.627.77 728.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.0 32.9%   
Avg P/E ratio x13.133.3 39.3%  
P/CF ratio (eoy) x4.426.5 16.7%  
Price / Book Value ratio x1.33.9 33.9%  
Dividend payout %18.725.1 74.7%   
Avg Mkt Cap Rs m3,9584,127 95.9%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m2,164607 356.7%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m12,1274,162 291.4%  
Other income Rs m22961 374.8%   
Total revenues Rs m12,3564,223 292.6%   
Gross profit Rs m1,009197 511.9%  
Depreciation Rs m59432 1,872.6%   
Interest Rs m41530 1,388.3%   
Profit before tax Rs m230197 116.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-7373 -99.9%   
Profit after tax Rs m302124 243.8%  
Gross profit margin %8.34.7 175.7%  
Effective tax rate %-31.737.0 -85.5%   
Net profit margin %2.53.0 83.7%  
BALANCE SHEET DATA
Current assets Rs m6,8841,629 422.7%   
Current liabilities Rs m8,4561,058 799.4%   
Net working cap to sales %-13.013.7 -94.5%  
Current ratio x0.81.5 52.9%  
Inventory Days Days6230 207.0%  
Debtors Days Days10834 320.2%  
Net fixed assets Rs m4,970556 893.4%   
Share capital Rs m11378 145.8%   
"Free" reserves Rs m2,875878 327.3%   
Net worth Rs m3,0201,069 282.4%   
Long term debt Rs m1,817159 1,145.2%   
Total assets Rs m13,3472,399 556.3%  
Interest coverage x1.67.6 20.5%   
Debt to equity ratio x0.60.1 405.5%  
Sales to assets ratio x0.91.7 52.4%   
Return on assets %5.46.4 83.8%  
Return on equity %10.011.6 86.3%  
Return on capital %13.318.5 72.2%  
Exports to sales %46.40.8 5,863.9%   
Imports to sales %14.21.4 1,017.0%   
Exports (fob) Rs m5,62233 17,086.6%   
Imports (cif) Rs m1,72858 2,963.5%   
Fx inflow Rs m5,84333 17,758.7%   
Fx outflow Rs m2,17363 3,439.0%   
Net fx Rs m3,669-30 -12,114.5%   
CASH FLOW
From Operations Rs m398127 314.1%  
From Investments Rs m-1,635-146 1,119.9%  
From Financial Activity Rs m1,30922 5,975.3%  
Net Cashflow Rs m713 2,848.0%  

Share Holding

Indian Promoters % 39.2 65.4 59.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.6 3.7 97.3%  
FIIs % 17.6 5.2 338.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 25.8 153.5%  
Shareholders   20,750 12,723 163.1%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Higher; IT Stocks Witness Buying Interest(11:30 am)

Stock markets in India are presently trading marginally higher. Sectoral indices are trading on a mixed note with stocks in the IT sector and FMCG sector witnessing maximum buying interest.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA 8-QTR ANALYSIS

COMPARE SHASUN PHARMA WITH

MARKET STATS